ZR2 Bioenergy Ltd

As of June 30, 2026, ZR2 Bioenergy Ltd carries a market capitalization of 375.80M, placing it among publicly traded companies globally. Its enterprise value stands at 375.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, ZR2 Bioenergy Ltd has 3.57M shares outstanding.

As of June 30, 2026, ZR2 Bioenergy Ltd trades at a trailing price-to-earnings ratio of 40.81.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 5.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, ZR2 Bioenergy Ltd recorded an income tax benefit of -342,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 8.88M, leaving 9.19M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, ZR2 Bioenergy Ltd's stock has declined approximately 64.48% over the past 52 weeks. The 50-day moving average sits at 123.83, while the 200-day moving average is 143.74.

Over the twelve months ended June 30, 2026, ZR2 Bioenergy Ltd generated - - in revenue and converted that into 9.19M in net income, yielding earnings per share of 2.59. EBITDA reached -7.09M, while operating income came in at -9.27M.

ZR2 Bioenergy Ltd's most recent stock split took place on May 27, 2022 with a 1:10 split ratio.